141 related articles for article (PubMed ID: 19641175)
1. Analysis of circulating tumor DNA to confirm somatic KRAS mutations.
Holdhoff M; Schmidt K; Donehower R; Diaz LA
J Natl Cancer Inst; 2009 Sep; 101(18):1284-5. PubMed ID: 19641175
[No Abstract] [Full Text] [Related]
2. [The frequency and spectrum of KRAS mutations in metastatic colorectal cancer].
Mazurenko NN; Gagarin IM; Tsyganova IV; Mochal'nikova VV; Breder VV
Vopr Onkol; 2013; 59(6):751-5. PubMed ID: 24624786
[TBL] [Abstract][Full Text] [Related]
3. [Consensus for KRAS gene mutation detection in colorectal carcinoma].
Pathology Quality Control Center of China, Consensus Group for KRAS Gene Mutation Detection in Colorectal Carcinoma
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):635-6. PubMed ID: 23157836
[No Abstract] [Full Text] [Related]
4. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
5. Origin and prognostic value of circulating KRAS mutations in lung cancer patients.
Gautschi O; Huegli B; Ziegler A; Gugger M; Heighway J; Ratschiller D; Mack PC; Gumerlock PH; Kung HJ; Stahel RA; Gandara DR; Betticher DC
Cancer Lett; 2007 Sep; 254(2):265-73. PubMed ID: 17449174
[TBL] [Abstract][Full Text] [Related]
6. KRAS mutations in primary and metastatic colorectal cancer.
Han CB; Li F; Ma JT; Zou HW
Int J Colorectal Dis; 2013 May; 28(5):731-2. PubMed ID: 22744738
[No Abstract] [Full Text] [Related]
7. KRAS and BRAF mutational status in primary colorectal tumors and related metastatic sites: biological and clinical implications.
Italiano A; Hostein I; Soubeyran I; Fabas T; Benchimol D; Evrard S; Gugenheim J; Becouarn Y; Brunet R; Fonck M; François E; Saint-Paul MC; Pedeutour F
Ann Surg Oncol; 2010 May; 17(5):1429-34. PubMed ID: 20049644
[TBL] [Abstract][Full Text] [Related]
8. Frequency and type of KRAS mutations in routine diagnostic analysis of metastatic colorectal cancer.
Neumann J; Zeindl-Eberhart E; Kirchner T; Jung A
Pathol Res Pract; 2009; 205(12):858-62. PubMed ID: 19679400
[TBL] [Abstract][Full Text] [Related]
9. Stromal cells do not share KRAS mutations that the epithelial component harbors in colorectal carcinomas.
Baloglu H; Yigit N
Cancer Lett; 2011 Sep; 308(1):118-21. PubMed ID: 21624768
[TBL] [Abstract][Full Text] [Related]
10. Setting future standards for KRAS testing in colorectal cancer.
van Krieken H; Tol J
Pharmacogenomics; 2009 Jan; 10(1):1-3. PubMed ID: 19102707
[No Abstract] [Full Text] [Related]
11. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.
Zou H; Taylor WR; Harrington JJ; Hussain FT; Cao X; Loprinzi CL; Levine TR; Rex DK; Ahnen D; Knigge KL; Lance P; Jiang X; Smith DI; Ahlquist DA
Gastroenterology; 2009 Feb; 136(2):459-70. PubMed ID: 19026650
[TBL] [Abstract][Full Text] [Related]
12. High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer.
Simi L; Pratesi N; Vignoli M; Sestini R; Cianchi F; Valanzano R; Nobili S; Mini E; Pazzagli M; Orlando C
Am J Clin Pathol; 2008 Aug; 130(2):247-53. PubMed ID: 18628094
[TBL] [Abstract][Full Text] [Related]
13. Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.
Sasaki H; Okuda K; Kawano O; Endo K; Yukiue H; Yokoyama T; Yano M; Fujii Y
Oncol Rep; 2007 Sep; 18(3):623-8. PubMed ID: 17671710
[TBL] [Abstract][Full Text] [Related]
14. Enhancing detection of circulating tumor cells with activating KRAS oncogene in patients with colorectal cancer by weighted chemiluminescent membrane array method.
Yang MJ; Chiu HH; Wang HM; Yen LC; Tsao DA; Hsiao CP; Chen YF; Wang JY; Lin SR
Ann Surg Oncol; 2010 Feb; 17(2):624-33. PubMed ID: 19937133
[TBL] [Abstract][Full Text] [Related]
15. KRAS mutation profile in colorectal carcinoma and novel mutation--internal tandem duplication in KRAS.
Wójcik P; Kulig J; Okoń K; Zazula M; Moździoch I; Niepsuj A; Stachura J
Pol J Pathol; 2008; 59(2):93-6. PubMed ID: 18669174
[TBL] [Abstract][Full Text] [Related]
16. The detection of double mutations in KRAS depends on the mutation-detection assay used.
Hostein I; Lamy A; Faur N; Primois C; Verdon S; Sabourin JC; Soubeyran I
Clin Chem; 2011 Jul; 57(7):1077-9. PubMed ID: 21441420
[No Abstract] [Full Text] [Related]
17. Novel multiple, monoallelic KRAS mutations at codon 12 and 13.
Keller G; Geist B; Slotta-Huspenina J; Langer R; Nagl F; Fend F; Höfler H; Perren A
Int J Cancer; 2009 Dec; 125(11):2744-5. PubMed ID: 19521964
[No Abstract] [Full Text] [Related]
18. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
[TBL] [Abstract][Full Text] [Related]
19. Should KRAS mutations be considered an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab?
Garassino MC; Farina G; Rossi A; Martelli O; Torri V
J Clin Oncol; 2008 May; 26(15):2600; author reply 2601-2. PubMed ID: 18487581
[No Abstract] [Full Text] [Related]
20. [Mutational analysis of KRAS prior to targeted therapy in colorectal cancer. Quality control of molecular pathological methods in Sweden].
Enlund F; Helenius G; Palmqvist R; Edsjö A; Sundström M
Lakartidningen; 2010 Feb 3-9; 107(5):255-9. PubMed ID: 20297566
[No Abstract] [Full Text] [Related]
[Next] [New Search]
